|
EDC3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.257600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.500300E-02 |
| Normal-vs-Stage2 |
8.314800E-01 |
| Normal-vs-Stage3 |
1.459620E-01 |
| Normal-vs-Stage4 |
5.452600E-01 |
| Stage1-vs-Stage2 |
1.311830E-01 |
| Stage1-vs-Stage3 |
6.593800E-04 |
| Stage1-vs-Stage4 |
3.007600E-02 |
| Stage2-vs-Stage3 |
3.575800E-01 |
| Stage2-vs-Stage4 |
7.719400E-01 |
| Stage3-vs-Stage4 |
5.068000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.164600E-01 |
| Normal-vs-AfricanAmerican |
3.696200E-01 |
| Normal-vs-Asian |
2.281600E-01 |
| Caucasian-vs-AfricanAmerican |
3.570600E-01 |
| Caucasian-vs-Asian |
3.431400E-01 |
| AfricanAmerican-vs-Asian |
6.999400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.788000E-01 |
| Normal-vs-Female |
1.808360E-01 |
| Male-vs-Female |
4.513500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.069800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.404000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.416600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.735600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.266000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.629600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.971400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.955700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.241400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.974800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.622500E-04 |
| Normal-vs-Grade 2 |
1.388400E-01 |
| Normal-vs-Grade 3 |
3.413200E-01 |
| Normal-vs-Grade 4 |
1.709840E-01 |
| Grade 1-vs-Grade 2 |
1.643590E-02 |
| Grade 1-vs-Grade 3 |
2.226400E-04 |
| Grade 1-vs-Grade 4 |
9.50170000000305E-05 |
| Grade 2-vs-Grade 3 |
4.424000E-03 |
| Grade 2-vs-Grade 4 |
8.380900E-03 |
| Grade 3-vs-Grade 4 |
5.144600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.836300E-02 |
| Normal-vs-ccB subtype |
3.497400E-01 |
| ccA subtype-vs-ccB subtype |
2.658600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.760600E-01 |
| Normal-vs-N1 |
7.040800E-01 |
| N0-vs-N1 |
4.660400E-01 |
|
|
